Interpretation of Urine Albumin-to-Creatinine Ratio with Microalbumin <0.2 and Creatinine 95
A urine albumin-to-creatinine ratio with microalbumin <0.2 mg/dL and creatinine 95 mg/dL indicates normal renal function with no evidence of microalbuminuria. This result falls well within normal limits and suggests healthy kidney function.
Understanding the Albumin-to-Creatinine Ratio (ACR)
The albumin-to-creatinine ratio is calculated as follows:
- ACR = (albumin in mg/dL) ÷ (creatinine in g/dL)
- Since creatinine is typically reported in mg/dL, we convert: 95 mg/dL = 0.95 g/dL
- Therefore, ACR = (<0.2 mg/dL) ÷ (0.95 g/dL) = <21 mg/g
According to the National Kidney Foundation guidelines, normal ACR values are defined as:
- Normal: ≤30 mg/g creatinine 1
- Microalbuminuria: >30 to 300 mg/g creatinine 1
- Macroalbuminuria: >300 mg/g creatinine 1
Clinical Significance
The calculated ACR of <21 mg/g is below the threshold of 30 mg/g, indicating:
- No evidence of microalbuminuria
- Normal kidney function
- No indication of early diabetic nephropathy or other kidney damage
Recommendations for Follow-up
Based on these normal findings:
- For patients without risk factors: Routine annual screening is appropriate 1
- For patients with diabetes: Continue annual screening for microalbuminuria 1
- For patients with hypertension or family history of CKD: Annual screening is recommended 1
Important Considerations
Proper Collection Technique:
Potential False Negatives/Positives:
- Transient elevations in urinary albumin can occur with:
- Short-term hyperglycemia
- Exercise
- Urinary tract infections
- Marked hypertension
- Heart failure
- Acute febrile illness 1
- Transient elevations in urinary albumin can occur with:
Confirmation of Results:
- If microalbuminuria is suspected despite normal results, repeat testing is recommended
- Persistent microalbuminuria is defined as 2 of 3 measurements above the reference range 1
Clinical Algorithm for ACR Interpretation
Normal ACR (<30 mg/g):
- Continue routine annual screening
- Optimize management of any underlying conditions (diabetes, hypertension)
Microalbuminuria (30-300 mg/g):
- Confirm with repeat testing (2 of 3 samples over 3-6 months)
- If confirmed, initiate ACE inhibitor or ARB therapy
- Optimize blood pressure control (<130/80 mmHg)
- Optimize glycemic control if diabetic (HbA1c <7%)
- Retest within 6 months to assess treatment response 1
Macroalbuminuria (>300 mg/g):
- Confirm with repeat testing
- Aggressive treatment with ACE inhibitor/ARB
- Consider nephrology referral
The current result of <21 mg/g places the patient firmly in the normal category, indicating healthy kidney function with no evidence of early kidney damage.